USD/CAD’s recovery extended higher today but stays below 1.4115 resistance. Intraday bias remains neutral first. On the upside, firm break of 1.4115 will suggest that pullback from 1.4247 has completed, ahead of 38.2% retracement of Read more…
GBP/JPY is staying in consolidations below 219.56 and intraday bias stays neutral. Downside should be contained by 216.39 support to bring rebound. On the upside, above 219.56 will extend larger up trend and target 220.90 Read more…
EUR/JPY is staying in sideway trading and intraday bias remains neutral. While the price actions from 182.10 are looking corrective, stronger rebound cannot be ruled out. On the upside, firm break of 186.30 will resume Read more…
Intraday bias in EUR/GBP stays neutral at this point. Further decline is expected as long as 0.8543 resistance holds. Below 0.8482 minor support will bring retest of 0.8453 first. Firm break there and sustained trading Read more…
EUR/AUD’s extended decline and break of 1.6306 support suggests that rebound from 1.6108 has already completed at 1.6617. Intraday bias is now on the downside for retesting 1.6108 low first. Firm break there will resume Read more…
EUR/CHF recovered today but stays in range below 0.9278. Intraday bias remains neutral for consolidations. After all, with 0.9210 support intact, further rally is still in favor. On the upside, break 0.9278 will resume the Read more…
Most large mergers do not die in a courtroom. They die of exhaustion. The lawyers stay expensive. The financing goes stale. The executives who staked their reputations on the thing start quietly updating their contact Read more…
Ready to retire overseas but not sure where to start? In this episode, Kathleen Peddicord—founder and publisher of Live and Invest Overseas—breaks down why retiring abroad is becoming mainstream and gives you a practical framework Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal Now that summer is here, we’re Read more…
For the first time in the program’s history, Medicare is covering weight-loss drugs, and the price tag looks almost too good to pass up. Beginning July 1, eligible Part D enrollees can access medications including Read more…